Survival and characteristics of lymph node involvement in patients with N1 non-small cell lung cancer

Lung Cancer

Volumn 43, Issue 2, 2004, Pages 151-157

  Osaki, Toshihiro ^a   Nagashima, Akira ^a   Yoshimatsu, Takashi ^a   Tashima, Yuko ^a   Yasumoto, Kosei ^b  

^a KITAKYUSHU MUNICIPAL MEDICAL CENTER   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Lymph node involvement; N1 disease; Non small cell lung cancer; Prognosis; Surgery

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE;

EID: 1642575172     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2003.08.020     Document Type: Article

References (19)

1. Mountain C.F. Revisions in the international staging system for lung cancer. Chest. 111:1997;1710-1717.
2. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann. Thorac. Surg. 67:1999;1572-1576.
3. Yoshino I., Nakanishi R., Osaki T., Takenoyama M., Taga S., Hanagiri T. et al. Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest. 116:1999;144-149.
4. Naruke T., Tsuchiya R., Kondo H., Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann. Thorac. Surg. 71:2001;1759-1764.
5. Inoue K., Sato M., Fujimura S., Sakurada A., Takahashi S., Usuda K.et al. Prognostic assessment of 1310 patients with non-small-cell lung cancer who underwent complete resection from 1980 to 1993. J. Thorac. Cardiovasc. Surg. 116:1998;407-411.
6. Van Velzen E., Snijder R.J., Brutel de la Riviere A., Elbers H.J.J., Van den Bosch J.M.M. Type of lymph node involvement influences survival rates in T1N1M0 non-small cell lung carcinoma. Lymph node involvement by direct extension compared with lobar and hilar node metastases. Chest. 110:1996;1469-1473.
7. Van Velzen E., Snijder R.J., Brutel de la Riviere A., Elbers H.R.J., Van den Bosch J.M.M. Lymph node type as a prognostic factor for survival in T2N1M0 non-small cell lung carcinoma. Ann. Thorac. Surg. 63:1997;1436-1440.
8. Naruke T., Suemasu K., Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J. Thorac. Cardiovasc. Surg. 76:1978;832-839.
9. Yano T., Yokoyama H., Inoue T., Asoh H., Tayama K., Ichinose Y. Surgical results and prognostic factors of pathologic N1 disease in non-small-cell carcinoma of the lung. Significance of N1 level: lobar or hilar nodes. J. Thorac. Cardiovasc. Surg. 107:1994;1398-1402.
10. Sawyer T.E., Bonner J.A., Gould P.M., Foote R.L., Deschamps C., Lange C.M.et al. Factors predicting patterns of recurrence after resection of N1 non-small cell lung carcinoma. Ann. Thorac. Surg. 68:1999;1171-1176.
11. Van Velzen E., Brutel de la Riviere A., Elbers H.J.J., Lammers J.W.J., Van den Bosch J.M.M. Type of lymph node involvement and survival in pathologic N1 stage III non-small cell lung carcinoma. Ann. Thorac. Surg. 67:1999;903-907.
12. Martini N., Burt M.E., Bains M.S., McCormack P.M., Rusch V.W., Ginsberg R.J. Survival after resection of stage II non-small cell lung cancer. Ann. Thorac. Surg. 54:1992;460-466.
13. Andre F., Grunenwald D., Pignon J.P., Dujon A., Pujol J.L., Brichon P.Y.et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J. Clin. Oncol. 18:2000;2981-2989.
14. Nakanishi R., Osaki T., Nakanishi K., Yoshino I., Yoshimatsu T., Watanabe H.et al. Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer. Ann. Thorac. Surg. 64:1997;342-348.
15. Mountain C.F., Dresler C.M. Regional lymph node classification for lung cancer staging. Chest. 111:1997;1718-1723.
16. Asamura H., Suzuki K., Kondo H., Tsuchiya R. Where is the boundary between N1 and N2 stations in lung cancer? Ann. Thorac. Surg. 70:2000;1839-1846.
17. Keller S.M., Adak S., Wagner H., Herskovic A., Komaki R., Brooks B.J.et al. A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. N. Engl. J. Med. 343:2000;1217-1222.
18. Ettinger D.S., Cox J.D., Ginsberg R.J., Komaki R., Kris M.G., Livingston R.B.et al. NCCN non-small-cell lung cancer practice guidelines. Oncology. 10(Suppl):1996;81-111.
19. Pisters K.M.W., Ginsberg R.J., Giroux D.J., Putnam J.B. Jr., Kris M.G., Johnson D.H.et al. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J. Thorac. Cardiovasc. Surg. 119:2000;429-439.